Related references
Note: Only part of the references are listed.Procoagulant and fibrinolytic activity after polytrauma in rat
Xiaowu Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients
Michael P. Chapman et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2016)
Fibrinolytic shutdown: fascinating theory but randomized controlled trial data are needed
Ian Roberts
TRANSFUSION (2016)
Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients
Michael P. Chapman et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2016)
Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice
Nuha Hijazi et al.
BLOOD (2015)
Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid
Ernest E. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)
Prevalence and impact of admission hyperfibrinolysis in severely injured pediatric trauma patients
Ioannis N. Liras et al.
SURGERY (2015)
Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid
Ernest E. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)
HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial
Ian Roberts et al.
TRIALS (2014)
Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial
Ian Roberts et al.
CRITICAL CARE (2014)
Applying results from clinical trials: tranexamic acid in trauma patients
Ian Roberts et al.
JOURNAL OF INTENSIVE CARE (2014)
The incidence and magnitude of fibrinolytic activation in trauma patients
I. Raza et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Tranexamic acid in trauma: How should we use it?
Lena M. Napolitano et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2013)
Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator
M. M. C. G. Silva et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
Yashbir Dewan et al.
TRIALS (2012)
Effect of consent rituals on mortality in emergency care research
Ian Roberts et al.
LANCET (2011)
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
Haleema Shakur et al.
LANCET (2010)
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
Haleema Shakur et al.
TRIALS (2010)
Share Paper
